Paralyzed patient started playing chess by implanting Neuralink chip in his brain, Elon Musk said telepathy, watch viral video

Paralyzed patient started playing chess by implanting Neuralink chip in his brain, Elon Musk said telepathy, watch viral video

[ad_1]

Elon Musk’s brain-chip startup Neuralink showed off its first patient capable of playing online chess and video games with his thoughts using Neuralink’s brain chip. A video was widely shared on social media in which the patient was shown getting a chip implanted. The patient in the video introduced himself as Noland Arbaugh, 29, who was paralyzed from the shoulders down after a diving accident. Let us tell you, Neuralink is a brain technology startup founded by Elon Musk and the implant by Neuralink allows a patient to use his thoughts to control the computer.

Neuralink’s future plans

Earlier, Musk had said that the company will start working with patients who have severe physical limitations like cervical spinal cord impairment or quadriplegia. “I quit playing that game,” Arbaugh said on Elon Musk’s social platform X. He added: “It has already changed my life.” “The surgery was extremely easy.”

The 29-year-old patient said he had injured his spinal cord in a “freak diving accident” eight years ago. He further said that he was discharged from the hospital a day after the Neuralink procedure in January, which went smoothly. He added that “there is still work to be done” to improve the technology.

How does the Neuralink device work?

The Neuralink device has more electrodes than other devices and may have more potential applications in the future and the technology works without the need for wired connections to external devices. In a post on X on Wednesday, Musk said the device could have the ability to restore vision. “BlindSight is the next product after Telepathy,” he wrote, referring to the name of an implant for paralyzed patients.

“I’m happy for the guy that he’s able to interface with the computer in a way he wasn’t able to before the transplant,” said Kip Alan Ludwig, co-director of the Wisconsin Institute for Translational Neuroengineering.



[ad_2]

Source link